| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intraocular Pressure | 51 | 2002 | 143 | 3.050 |
Why?
|
| Aqueous Humor | 24 | 2004 | 51 | 2.170 |
Why?
|
| Eye | 18 | 2008 | 89 | 1.680 |
Why?
|
| Rabbits | 58 | 2004 | 509 | 1.540 |
Why?
|
| Adrenergic alpha-Agonists | 14 | 2002 | 57 | 1.360 |
Why?
|
| Ciliary Body | 17 | 2003 | 52 | 1.190 |
Why?
|
| Adrenergic beta-Agonists | 9 | 2003 | 92 | 1.160 |
Why?
|
| Receptors, Drug | 7 | 2002 | 31 | 1.080 |
Why?
|
| Clenbuterol | 6 | 2003 | 9 | 1.050 |
Why?
|
| Analgesics | 6 | 2014 | 118 | 1.040 |
Why?
|
| Imidazoles | 13 | 2002 | 175 | 0.960 |
Why?
|
| Norepinephrine | 18 | 2003 | 276 | 0.950 |
Why?
|
| Receptors, Opioid, kappa | 6 | 2008 | 37 | 0.940 |
Why?
|
| Ocular Hypotension | 7 | 2002 | 10 | 0.920 |
Why?
|
| Benzomorphans | 4 | 2005 | 4 | 0.870 |
Why?
|
| Animals | 86 | 2014 | 20881 | 0.760 |
Why?
|
| Cyclic AMP | 16 | 2002 | 223 | 0.740 |
Why?
|
| Iris | 13 | 2003 | 27 | 0.740 |
Why?
|
| Pupil | 20 | 2001 | 51 | 0.710 |
Why?
|
| Dopamine Agonists | 4 | 2002 | 68 | 0.710 |
Why?
|
| Hindlimb Suspension | 4 | 2003 | 11 | 0.690 |
Why?
|
| Nictitating Membrane | 13 | 2002 | 15 | 0.680 |
Why?
|
| Dose-Response Relationship, Drug | 26 | 2003 | 1745 | 0.680 |
Why?
|
| Dopamine Agents | 7 | 1993 | 56 | 0.660 |
Why?
|
| Ocular Hypertension | 9 | 2002 | 43 | 0.650 |
Why?
|
| Tetrahydronaphthalenes | 5 | 2002 | 20 | 0.620 |
Why?
|
| Sympathetic Nervous System | 15 | 2002 | 81 | 0.590 |
Why?
|
| Naphazoline | 3 | 2002 | 3 | 0.570 |
Why?
|
| Muscle, Skeletal | 5 | 2003 | 396 | 0.570 |
Why?
|
| Adrenergic alpha-Antagonists | 7 | 2002 | 32 | 0.500 |
Why?
|
| Anesthetics, Dissociative | 1 | 2014 | 11 | 0.490 |
Why?
|
| Drug Repositioning | 1 | 2014 | 8 | 0.490 |
Why?
|
| Receptors, Opioid | 3 | 2012 | 60 | 0.480 |
Why?
|
| Atrial Natriuretic Factor | 4 | 2002 | 54 | 0.460 |
Why?
|
| Ketamine | 1 | 2014 | 57 | 0.450 |
Why?
|
| Antihypertensive Agents | 5 | 2001 | 498 | 0.450 |
Why?
|
| Naltrexone | 4 | 2003 | 195 | 0.450 |
Why?
|
| Retinal Degeneration | 2 | 2012 | 75 | 0.450 |
Why?
|
| Sympathectomy | 12 | 2002 | 24 | 0.440 |
Why?
|
| Ischemia | 2 | 2012 | 229 | 0.440 |
Why?
|
| Administration, Topical | 14 | 2002 | 111 | 0.410 |
Why?
|
| Cats | 17 | 2002 | 292 | 0.400 |
Why?
|
| Receptors, Dopamine D2 | 4 | 2000 | 109 | 0.390 |
Why?
|
| Pyrrolidines | 2 | 2001 | 45 | 0.390 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 2 | 2000 | 8 | 0.350 |
Why?
|
| Trabecular Meshwork | 2 | 2000 | 22 | 0.350 |
Why?
|
| Male | 61 | 2011 | 37321 | 0.350 |
Why?
|
| Analgesics, Opioid | 2 | 2012 | 498 | 0.330 |
Why?
|
| Neuroprotective Agents | 1 | 2012 | 317 | 0.330 |
Why?
|
| Eye Diseases | 2 | 2008 | 38 | 0.320 |
Why?
|
| Dopamine Antagonists | 4 | 2002 | 65 | 0.300 |
Why?
|
| Cyclic GMP | 5 | 2002 | 99 | 0.300 |
Why?
|
| Aporphines | 2 | 1999 | 5 | 0.290 |
Why?
|
| Benzofurans | 7 | 2002 | 21 | 0.280 |
Why?
|
| Quinoxalines | 5 | 2002 | 78 | 0.280 |
Why?
|
| Electric Stimulation | 9 | 2002 | 218 | 0.280 |
Why?
|
| Ergolines | 5 | 1988 | 19 | 0.270 |
Why?
|
| Imidazoline Receptors | 7 | 2002 | 8 | 0.270 |
Why?
|
| Isoproterenol | 14 | 2000 | 163 | 0.270 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 4 | 2002 | 17 | 0.270 |
Why?
|
| Spermidine | 2 | 2003 | 21 | 0.270 |
Why?
|
| Metoclopramide | 5 | 1998 | 21 | 0.260 |
Why?
|
| Receptors, Adrenergic, alpha | 3 | 1992 | 40 | 0.260 |
Why?
|
| Hypolipidemic Agents | 2 | 1996 | 82 | 0.240 |
Why?
|
| Ocular Physiological Phenomena | 2 | 2002 | 8 | 0.230 |
Why?
|
| Natriuretic Peptide, C-Type | 1 | 2004 | 5 | 0.230 |
Why?
|
| Inositol Phosphates | 1 | 2003 | 28 | 0.230 |
Why?
|
| Quinolines | 3 | 1993 | 48 | 0.220 |
Why?
|
| Pertussis Toxin | 3 | 2003 | 72 | 0.220 |
Why?
|
| Receptors, Opioid, delta | 1 | 2003 | 37 | 0.220 |
Why?
|
| Naphthalenes | 3 | 1990 | 47 | 0.220 |
Why?
|
| Yohimbine | 7 | 2002 | 41 | 0.220 |
Why?
|
| Adrenergic alpha-2 Receptor Antagonists | 2 | 2001 | 15 | 0.220 |
Why?
|
| Signal Transduction | 4 | 2012 | 2689 | 0.220 |
Why?
|
| Antidepressive Agents | 2 | 2014 | 216 | 0.220 |
Why?
|
| Calcium Phosphates | 1 | 2002 | 13 | 0.220 |
Why?
|
| GTP-Binding Proteins | 1 | 2003 | 231 | 0.210 |
Why?
|
| Electroacupuncture | 1 | 2002 | 1 | 0.210 |
Why?
|
| Biogenic Polyamines | 1 | 2002 | 8 | 0.210 |
Why?
|
| Neurosecretory Systems | 1 | 2002 | 21 | 0.210 |
Why?
|
| Biodegradation, Environmental | 1 | 2002 | 92 | 0.210 |
Why?
|
| Muscle Proteins | 1 | 2003 | 94 | 0.210 |
Why?
|
| Virulence Factors, Bordetella | 3 | 2001 | 60 | 0.210 |
Why?
|
| Cysteine | 3 | 1999 | 112 | 0.210 |
Why?
|
| Mydriasis | 2 | 1999 | 3 | 0.210 |
Why?
|
| Rats | 14 | 2009 | 5300 | 0.200 |
Why?
|
| Nanotechnology | 1 | 2002 | 109 | 0.200 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2008 | 2083 | 0.200 |
Why?
|
| Female | 30 | 2011 | 38074 | 0.190 |
Why?
|
| Narcotic Antagonists | 5 | 2009 | 184 | 0.190 |
Why?
|
| Pain | 1 | 2005 | 472 | 0.190 |
Why?
|
| Injections, Intraventricular | 5 | 2001 | 50 | 0.190 |
Why?
|
| Drug Delivery Systems | 1 | 2002 | 236 | 0.190 |
Why?
|
| 3',5'-Cyclic-GMP Phosphodiesterases | 1 | 2000 | 10 | 0.180 |
Why?
|
| Body Fluids | 1 | 2000 | 41 | 0.180 |
Why?
|
| Sympathomimetics | 4 | 1981 | 16 | 0.180 |
Why?
|
| 8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 1999 | 9 | 0.170 |
Why?
|
| Oxymetazoline | 2 | 1996 | 3 | 0.170 |
Why?
|
| 2',3'-Cyclic-Nucleotide Phosphodiesterases | 1 | 1999 | 18 | 0.170 |
Why?
|
| Sulfinic Acids | 2 | 1996 | 3 | 0.170 |
Why?
|
| Serotonin Receptor Agonists | 1 | 1999 | 34 | 0.170 |
Why?
|
| In Vitro Techniques | 6 | 2002 | 765 | 0.170 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 1999 | 47 | 0.170 |
Why?
|
| Lisuride | 1 | 1998 | 3 | 0.160 |
Why?
|
| Ligands | 2 | 2012 | 317 | 0.160 |
Why?
|
| Receptors, Dopamine | 3 | 1990 | 119 | 0.160 |
Why?
|
| Thiophenes | 2 | 1990 | 76 | 0.160 |
Why?
|
| Superior Cervical Ganglion | 1 | 1997 | 6 | 0.150 |
Why?
|
| Insulin | 7 | 1982 | 619 | 0.150 |
Why?
|
| Brimonidine Tartrate | 5 | 2002 | 13 | 0.150 |
Why?
|
| Epinephrine | 10 | 2003 | 103 | 0.140 |
Why?
|
| Radioimmunoassay | 3 | 2001 | 164 | 0.140 |
Why?
|
| Oxazoles | 1 | 1996 | 17 | 0.140 |
Why?
|
| Muscle Contraction | 5 | 1991 | 210 | 0.140 |
Why?
|
| Proteins | 1 | 2000 | 474 | 0.140 |
Why?
|
| Enkephalins | 1 | 1996 | 89 | 0.130 |
Why?
|
| Calcium | 2 | 1996 | 929 | 0.130 |
Why?
|
| Glucagon | 3 | 1980 | 22 | 0.130 |
Why?
|
| Nitroprusside | 3 | 2000 | 42 | 0.130 |
Why?
|
| Dopamine | 3 | 2002 | 474 | 0.120 |
Why?
|
| Quinolizines | 1 | 1994 | 4 | 0.120 |
Why?
|
| Cells, Cultured | 5 | 2000 | 2673 | 0.120 |
Why?
|
| Timolol | 4 | 1988 | 10 | 0.120 |
Why?
|
| Cebus | 7 | 1988 | 9 | 0.120 |
Why?
|
| Antioxidants | 1 | 1996 | 304 | 0.120 |
Why?
|
| Analysis of Variance | 3 | 2001 | 1040 | 0.120 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 1988 | 189 | 0.110 |
Why?
|
| Receptors, Adrenergic | 3 | 1990 | 68 | 0.110 |
Why?
|
| Domperidone | 3 | 1993 | 11 | 0.110 |
Why?
|
| Motor Activity | 2 | 2008 | 621 | 0.110 |
Why?
|
| Disease Models, Animal | 3 | 2011 | 2550 | 0.110 |
Why?
|
| Naloxone | 3 | 2009 | 56 | 0.110 |
Why?
|
| Blood Glucose | 5 | 1979 | 631 | 0.100 |
Why?
|
| Muscle Fibers, Slow-Twitch | 2 | 2002 | 7 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 234 | 0.100 |
Why?
|
| Brain | 2 | 2001 | 2176 | 0.100 |
Why?
|
| Retinal Vessels | 2 | 2011 | 74 | 0.100 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2014 | 266 | 0.100 |
Why?
|
| Opioid Peptides | 1 | 2012 | 17 | 0.100 |
Why?
|
| Chromatography, Ion Exchange | 2 | 2003 | 73 | 0.100 |
Why?
|
| Retinal Neovascularization | 1 | 2011 | 7 | 0.100 |
Why?
|
| Frizzled Receptors | 1 | 2011 | 8 | 0.100 |
Why?
|
| Raclopride | 2 | 2002 | 15 | 0.100 |
Why?
|
| Blood-Retinal Barrier | 1 | 2011 | 15 | 0.100 |
Why?
|
| Sympatholytics | 2 | 1981 | 11 | 0.100 |
Why?
|
| Glaucoma | 2 | 1990 | 50 | 0.100 |
Why?
|
| Water | 6 | 1993 | 230 | 0.100 |
Why?
|
| Prodrugs | 2 | 1988 | 54 | 0.090 |
Why?
|
| Blood Pressure | 6 | 2002 | 1451 | 0.090 |
Why?
|
| Neovascularization, Physiologic | 1 | 2011 | 164 | 0.090 |
Why?
|
| Immunohistochemistry | 3 | 2009 | 1174 | 0.090 |
Why?
|
| Stereoisomerism | 4 | 2000 | 169 | 0.090 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 244 | 0.090 |
Why?
|
| Quinazolines | 2 | 2000 | 70 | 0.090 |
Why?
|
| Nifedipine | 1 | 1990 | 40 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2011 | 167 | 0.090 |
Why?
|
| Retinal Diseases | 1 | 1990 | 40 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 626 | 0.080 |
Why?
|
| Ischemic Preconditioning | 1 | 2009 | 31 | 0.080 |
Why?
|
| Narcotics | 1 | 2009 | 65 | 0.080 |
Why?
|
| Tritium | 2 | 2002 | 101 | 0.080 |
Why?
|
| Levobunolol | 1 | 1988 | 1 | 0.080 |
Why?
|
| Catecholamines | 2 | 1979 | 73 | 0.080 |
Why?
|
| Morphine | 1 | 2009 | 76 | 0.080 |
Why?
|
| Salvia | 1 | 2008 | 1 | 0.080 |
Why?
|
| Diterpenes, Clerodane | 1 | 2008 | 2 | 0.080 |
Why?
|
| Humans | 10 | 2014 | 68618 | 0.080 |
Why?
|
| Reflex, Pupillary | 2 | 1985 | 5 | 0.080 |
Why?
|
| Apomorphine | 1 | 1987 | 48 | 0.080 |
Why?
|
| Eye Proteins | 2 | 2011 | 160 | 0.070 |
Why?
|
| Medetomidine | 3 | 1993 | 6 | 0.070 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 1979 | 195 | 0.070 |
Why?
|
| Drug Interactions | 3 | 1998 | 289 | 0.070 |
Why?
|
| Injections, Intravenous | 3 | 1996 | 215 | 0.070 |
Why?
|
| Epithelium | 2 | 1996 | 172 | 0.070 |
Why?
|
| Neural Inhibition | 1 | 1987 | 80 | 0.070 |
Why?
|
| Ophthalmic Solutions | 2 | 1999 | 39 | 0.070 |
Why?
|
| Dioxanes | 2 | 1999 | 15 | 0.070 |
Why?
|
| Thiazines | 1 | 1986 | 4 | 0.070 |
Why?
|
| Reperfusion Injury | 1 | 2009 | 320 | 0.070 |
Why?
|
| Xylazine | 1 | 1986 | 5 | 0.070 |
Why?
|
| Ketanserin | 1 | 1985 | 7 | 0.060 |
Why?
|
| Diuresis | 1 | 2005 | 20 | 0.060 |
Why?
|
| Diterpenes | 1 | 1985 | 42 | 0.060 |
Why?
|
| Disulfides | 2 | 1996 | 40 | 0.060 |
Why?
|
| Deoxyepinephrine | 1 | 1984 | 1 | 0.060 |
Why?
|
| Hypotension | 1 | 1985 | 74 | 0.060 |
Why?
|
| Respiration | 1 | 2005 | 91 | 0.060 |
Why?
|
| Ethanol | 2 | 1982 | 893 | 0.060 |
Why?
|
| Cardiovascular System | 1 | 2005 | 85 | 0.060 |
Why?
|
| GTP-Binding Protein Regulators | 1 | 2003 | 8 | 0.060 |
Why?
|
| Biological Transport | 1 | 2004 | 210 | 0.060 |
Why?
|
| Heart | 1 | 1988 | 850 | 0.060 |
Why?
|
| Synaptic Transmission | 1 | 2005 | 236 | 0.050 |
Why?
|
| Depression, Chemical | 2 | 1999 | 29 | 0.050 |
Why?
|
| Pigmentation | 1 | 2002 | 12 | 0.050 |
Why?
|
| Terbutaline | 5 | 1986 | 23 | 0.050 |
Why?
|
| Injections, Subcutaneous | 1 | 2003 | 87 | 0.050 |
Why?
|
| Nonlinear Dynamics | 1 | 2003 | 55 | 0.050 |
Why?
|
| Cocaine | 1 | 2008 | 555 | 0.050 |
Why?
|
| Endorphins | 1 | 2002 | 32 | 0.050 |
Why?
|
| Putrescine | 1 | 2002 | 17 | 0.050 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2002 | 5 | 0.050 |
Why?
|
| Benzamides | 1 | 2003 | 156 | 0.050 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2002 | 11 | 0.050 |
Why?
|
| Mesentery | 1 | 2002 | 17 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2003 | 202 | 0.050 |
Why?
|
| Sympathectomy, Chemical | 2 | 1995 | 6 | 0.050 |
Why?
|
| Piperazines | 1 | 2003 | 206 | 0.050 |
Why?
|
| Weight-Bearing | 1 | 2002 | 53 | 0.050 |
Why?
|
| Models, Biological | 2 | 2003 | 981 | 0.050 |
Why?
|
| Acetaldehyde | 1 | 1982 | 18 | 0.050 |
Why?
|
| Glyburide | 1 | 2001 | 19 | 0.050 |
Why?
|
| Random Allocation | 2 | 2002 | 442 | 0.050 |
Why?
|
| Acetates | 1 | 1982 | 74 | 0.050 |
Why?
|
| Islets of Langerhans | 1 | 1982 | 87 | 0.050 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2001 | 98 | 0.050 |
Why?
|
| Adipose Tissue | 1 | 2002 | 221 | 0.050 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 2000 | 18 | 0.050 |
Why?
|
| Glucose | 2 | 1980 | 307 | 0.050 |
Why?
|
| Prazosin | 1 | 1980 | 10 | 0.050 |
Why?
|
| Guanylate Cyclase | 1 | 2000 | 25 | 0.050 |
Why?
|
| Receptors, Dopamine D3 | 1 | 2000 | 12 | 0.050 |
Why?
|
| Indans | 1 | 2000 | 20 | 0.050 |
Why?
|
| Adenylyl Cyclases | 1 | 2000 | 94 | 0.050 |
Why?
|
| Drug Synergism | 1 | 2001 | 260 | 0.050 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2000 | 59 | 0.040 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2002 | 373 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2000 | 282 | 0.040 |
Why?
|
| Body Weight | 1 | 2002 | 554 | 0.040 |
Why?
|
| Neurons | 4 | 1987 | 881 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 1 | 2000 | 196 | 0.040 |
Why?
|
| Organ Size | 1 | 2000 | 242 | 0.040 |
Why?
|
| Piperidines | 1 | 2000 | 123 | 0.040 |
Why?
|
| Clonidine | 3 | 1986 | 66 | 0.040 |
Why?
|
| Spiperone | 1 | 1999 | 29 | 0.040 |
Why?
|
| Bone and Bones | 1 | 2000 | 145 | 0.040 |
Why?
|
| Cisterna Magna | 1 | 1999 | 3 | 0.040 |
Why?
|
| Spiro Compounds | 1 | 1999 | 14 | 0.040 |
Why?
|
| Conjunctiva | 1 | 1999 | 16 | 0.040 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 1999 | 28 | 0.040 |
Why?
|
| Microinjections | 1 | 1999 | 130 | 0.040 |
Why?
|
| Electroretinography | 2 | 2009 | 122 | 0.040 |
Why?
|
| Phosphines | 1 | 1999 | 5 | 0.040 |
Why?
|
| Adrenergic Agonists | 1 | 1979 | 5 | 0.040 |
Why?
|
| Time Factors | 6 | 1987 | 4655 | 0.040 |
Why?
|
| 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1 | 1998 | 10 | 0.040 |
Why?
|
| DNA Primers | 1 | 1999 | 302 | 0.040 |
Why?
|
| Calcium Channel Agonists | 1 | 1998 | 18 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1999 | 381 | 0.040 |
Why?
|
| Pyrazoles | 1 | 1980 | 190 | 0.040 |
Why?
|
| Isoenzymes | 1 | 1999 | 308 | 0.040 |
Why?
|
| Lighting | 2 | 1996 | 9 | 0.040 |
Why?
|
| Macaca nemestrina | 1 | 1997 | 23 | 0.040 |
Why?
|
| Kinetics | 2 | 1994 | 1047 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 710 | 0.040 |
Why?
|
| Swine | 1 | 1999 | 672 | 0.040 |
Why?
|
| Denervation | 1 | 1996 | 23 | 0.040 |
Why?
|
| Fura-2 | 1 | 1996 | 21 | 0.040 |
Why?
|
| DNA | 1 | 1999 | 597 | 0.030 |
Why?
|
| Sulpiride | 2 | 1988 | 20 | 0.030 |
Why?
|
| Quinpirole | 2 | 1988 | 26 | 0.030 |
Why?
|
| Cytosol | 1 | 1996 | 123 | 0.030 |
Why?
|
| Enkephalin, D-Penicillamine (2,5)- | 1 | 1996 | 7 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 2000 | 738 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2000 | 1753 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 1996 | 261 | 0.030 |
Why?
|
| Medulla Oblongata | 1 | 1995 | 19 | 0.030 |
Why?
|
| Cornea | 1 | 1995 | 76 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 1999 | 1664 | 0.030 |
Why?
|
| Blinking | 2 | 1985 | 8 | 0.030 |
Why?
|
| Uvea | 1 | 1994 | 2 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2000 | 2077 | 0.030 |
Why?
|
| Myocardium | 1 | 2000 | 1204 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 1996 | 431 | 0.030 |
Why?
|
| Catheters, Indwelling | 1 | 1994 | 72 | 0.030 |
Why?
|
| Pergolide | 2 | 1984 | 12 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta | 2 | 2002 | 153 | 0.030 |
Why?
|
| Benzazepines | 1 | 1992 | 104 | 0.030 |
Why?
|
| Idazoxan | 1 | 1991 | 1 | 0.020 |
Why?
|
| Chemical Phenomena | 2 | 1987 | 62 | 0.020 |
Why?
|
| Chemistry | 2 | 1987 | 45 | 0.020 |
Why?
|
| Capillary Permeability | 1 | 2011 | 69 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2011 | 95 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2011 | 46 | 0.020 |
Why?
|
| Receptors, LDL | 1 | 2011 | 72 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2011 | 396 | 0.020 |
Why?
|
| Retinal Artery Occlusion | 1 | 1990 | 7 | 0.020 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 1990 | 19 | 0.020 |
Why?
|
| Anesthesia | 2 | 1990 | 120 | 0.020 |
Why?
|
| Phenylephrine | 2 | 1981 | 61 | 0.020 |
Why?
|
| Peptides | 2 | 1971 | 455 | 0.020 |
Why?
|
| Albuterol | 2 | 1982 | 26 | 0.020 |
Why?
|
| Receptors, Dopamine D1 | 1 | 1990 | 87 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 290 | 0.020 |
Why?
|
| Oxygen | 1 | 2011 | 386 | 0.020 |
Why?
|
| Rats, Inbred BN | 1 | 2009 | 51 | 0.020 |
Why?
|
| Molecular Structure | 1 | 1990 | 397 | 0.020 |
Why?
|
| Somatostatin | 2 | 1979 | 36 | 0.020 |
Why?
|
| Colforsin | 2 | 1986 | 42 | 0.020 |
Why?
|
| Propranolol | 2 | 1980 | 103 | 0.020 |
Why?
|
| Mydriatics | 1 | 1988 | 4 | 0.020 |
Why?
|
| Genes, fos | 1 | 2008 | 22 | 0.020 |
Why?
|
| Decerebrate State | 1 | 1987 | 1 | 0.020 |
Why?
|
| Sclera | 1 | 1987 | 8 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2011 | 1692 | 0.020 |
Why?
|
| Hyperemia | 1 | 1987 | 14 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2009 | 954 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 1987 | 368 | 0.020 |
Why?
|
| Heart Rate | 1 | 1988 | 568 | 0.020 |
Why?
|
| Structure-Activity Relationship | 2 | 1981 | 420 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2011 | 2791 | 0.020 |
Why?
|
| Bromocriptine | 1 | 1984 | 8 | 0.010 |
Why?
|
| Ganglia, Sympathetic | 1 | 1984 | 4 | 0.010 |
Why?
|
| Oculomotor Muscles | 1 | 1984 | 54 | 0.010 |
Why?
|
| Metaproterenol | 1 | 1982 | 1 | 0.010 |
Why?
|
| Theophylline | 1 | 1982 | 22 | 0.010 |
Why?
|
| Acetic Acid | 1 | 1982 | 14 | 0.010 |
Why?
|
| Antiparkinson Agents | 1 | 1982 | 34 | 0.010 |
Why?
|
| Muscular Atrophy | 1 | 2002 | 35 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1982 | 532 | 0.010 |
Why?
|
| Species Specificity | 1 | 1981 | 303 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1982 | 304 | 0.010 |
Why?
|
| Ethanolamines | 1 | 1981 | 33 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1982 | 567 | 0.010 |
Why?
|
| Taurine | 1 | 1980 | 51 | 0.010 |
Why?
|
| Butoxamine | 1 | 1980 | 1 | 0.010 |
Why?
|
| Ephedrine | 1 | 1980 | 7 | 0.010 |
Why?
|
| Metoprolol | 1 | 1980 | 8 | 0.010 |
Why?
|
| Dobutamine | 1 | 1980 | 25 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 1981 | 218 | 0.010 |
Why?
|
| Mice | 1 | 2011 | 8474 | 0.010 |
Why?
|
| Haplorhini | 1 | 1978 | 44 | 0.010 |
Why?
|
| Papio | 1 | 1978 | 27 | 0.010 |
Why?
|
| Muscle, Smooth | 2 | 1971 | 117 | 0.010 |
Why?
|
| Fasting | 1 | 1978 | 75 | 0.010 |
Why?
|
| Bradykinin | 2 | 1971 | 157 | 0.010 |
Why?
|
| Glycogen | 1 | 1975 | 27 | 0.010 |
Why?
|
| Eledoisin | 1 | 1971 | 1 | 0.010 |
Why?
|
| Ileum | 1 | 1971 | 28 | 0.010 |
Why?
|
| Carboxylic Acids | 1 | 1971 | 24 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1971 | 124 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1971 | 64 | 0.010 |
Why?
|
| Sulfhydryl Compounds | 1 | 1971 | 73 | 0.010 |
Why?
|
| Amino Acids | 1 | 1971 | 131 | 0.010 |
Why?
|
| Amines | 1 | 1971 | 98 | 0.010 |
Why?
|
| Kallidin | 1 | 1965 | 9 | 0.000 |
Why?
|
| Blood | 1 | 1965 | 40 | 0.000 |
Why?
|
| Pharmacology | 1 | 1965 | 9 | 0.000 |
Why?
|
| Biological Assay | 1 | 1965 | 88 | 0.000 |
Why?
|
| Vasodilator Agents | 1 | 1965 | 138 | 0.000 |
Why?
|
| Dogs | 1 | 1965 | 490 | 0.000 |
Why?
|
| Research | 1 | 1965 | 214 | 0.000 |
Why?
|
| Liver Glycogen | 1 | 1975 | 10 | 0.000 |
Why?
|
| Muscles | 1 | 1975 | 158 | 0.000 |
Why?
|